Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening- Sixteen Kenyans missing in Russia after army recruitment
- Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
- Step by step instructions to Think about Disc Rates Across Various Banks
- Want to read more in 2026? Here's how to revive your love of books
- Industrial zone damaged in Negev, falls in Sharon area after Iran fires missiles towards Israel
- This Week In Space podcast: Episode 204 — A New NASA
- At least 55 injured in Russia after train crashes, overturns
- Are protests pushing Iran's Islamic regime toward a tipping point?
